Alnylam Pharmaceuticals, Inc.
2020 Q3 - 2025 Q4 (12 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 159,605 | 0.6% | 401,371 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 5,763 | 0.0% | 17,674 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 41,305 | 0.2% | 152,970 | 3/31/2025 |
| 2024 Q2 | 8/14/2024 | 3,228 | 0.0% | 13,283 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 18,886 | 0.1% | 126,367 | 3/31/2024 |
| 2022 Q2 | 8/15/2022 | 1,255 | 0.0% | 8,604 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 5,107 | 0.0% | 31,274 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 11,488 | 0.1% | 67,746 | 12/31/2021 |
| 2021 Q2 | 8/16/2021 | 259 | 0.0% | 1,525 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 1,172 | 0.0% | 8,302 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 1,171 | 0.0% | 9,012 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 983 | 0.0% | 6,753 | 9/30/2020 |